MTOR and Insulin resistance: It has been observed that gliflozins reduce insulin resistance by decreasing hepatic diacylglycerols, compounds associated with increased insulin resistance, and downregulate cellular signaling through the mammalian target of rapamycin (mTOR) pathway [195].